Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
431 Metastatic Breast Lobular Carcinoma to Unusual Sites: A Report of Three Cases and Review of Literature Department of Pathology Amira Emad Mohamed Elwy 2020
432 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2020
433 The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: A single tertiary oncology center Department of Radiotherapy and Nuclear medicine Dr. Dalia Osama Mohamed Ahmed 2020
434 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Department of Medical Oncology Dr. Abeer Elsayed Ali Ibrahim 2020
435 Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study Department of Clinical Pathology Dr. Engy adel shafeek 2020
436 Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Department of Anesthesia, Intensive care and Pain management Prof. Ashraf Amin Mohamed 2020
437 Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Department of Anesthesia, Intensive care and Pain management Dr. Rania Mohamed Abd-Elemam 2020
438 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2020
439 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2020
440 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2020